The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened ...

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against other stocks under $10 that ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The ...

ImmunityBio, Inc.’s IBRX share price has dipped by 6.65%, which has investors questioning if this is right time to buy.

In this article, we are going to take a look at where ImmunityBio Inc. (NASDAQ:IBRX) stands against other Tuesday’s worst-performing stocks. Wall Street’s main indices suffered a bloodbath on ...

The latest analyst rating for ImmunityBio (NASDAQ:IBRX) was provided by D. Boral Capital, and ImmunityBio maintained their buy rating. The last downgrade for ImmunityBio Inc happened on May 12 ...

1 Day IBRX -0.40% DJIA -1.33% S&P Mid Cap 400 0.83% Health Care/Life Sciences 0.14% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an aggregate of 33,333,334 shares of its ...

CULVER CITY, Calif., April 15, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has completed multiple submissions to the FDA including an sBLA for ...